Insider Trading & Ownership of Patrick J. Mahaffy

Location
W. Conshohocken, PA
Summary
The estimated net worth of Patrick J. Mahaffy is at least $74,413 dollars as of 01 Apr 2026. Patrick J. Mahaffy is the Director of Medicus Pharma Ltd. and owns shares of Medicus Pharma Ltd. (MDCX) stock worth about $74.4K.
Signature
/s/ Raza Bokhari, as Attorney-in-Fact, for Patrick J. Mahaffy
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Patrick J. Mahaffy and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.

Create free account and return here Already have an account? Sign in and return here

Quick Takeaways

  • Patrick J. Mahaffy has 3 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $74,413.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: Medicus Pharma Ltd. ($74,413).
  • Past-year value change for that position: .

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Source Evidence

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Patrick J. Mahaffy

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
MDCX, MDCXW Medicus Pharma Ltd. Director $74,413 30 Mar 2026
CLVS Clovis Oncology, Inc. President and Chief Executive Officer, Director 01 Mar 2022
FLXN Flexion Therapeutics Inc Director 19 Nov 2021

Insider Transactions Reported by Patrick J. Mahaffy:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .